newsfilter
← Latest News
PR Newswire·

Inhibrx Announces Participation in Upcoming Scientific Conferences

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company with a pipeline of novel biologic...